Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome

Background: Lennox-Gastaut syndrome (LGS) is a severe form of childhood-onset epilepsy associated with serious injuries due to frequent and severe seizures. Of the antiepileptic drugs (AEDs) approved for LGS, clobazam is a more recent market entrant, having been approved in October 2011. Recent AED...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Mark Access Health Policy
Glavni autori: François, Clément, Stern, John M., Ogbonnaya, Augustina, Lokhandwala, Tasneem, Landsman-Blumberg, Pamela, Duhig, Amy, Shen, Vivienne, Tan, Robin
Format: Artigo
Jezik:Inglês
Izdano: Routledge 2017
Teme:
Transferred Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5508372/
https://ncbi.nlm.nih.gov/pubmed/28740620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20016689.2017.1318691
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items